Chinese english Germany Japanese Korea

2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)-

2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)- Struktur
916514-10-8
CAS-Nr.
916514-10-8
Englisch Name:
2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)-
Synonyma:
2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)-
CBNumber:
CB22616023
Summenformel:
C28H37N5O2
Molgewicht:
475.63
MOL-Datei:
916514-10-8.mol
Request For Quotation

2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)- Eigenschaften

Siedepunkt:
684.6±65.0 °C(Predicted)
Dichte
1.28±0.1 g/cm3(Predicted)
pka
9.53±0.10(Predicted)

Sicherheit

2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)- Chemische Eigenschaften,Einsatz,Produktion Methoden

2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
NCE Biomedical Co.,Ltd. 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
China 1493 55
Shanghai Changyan Chem & Tech Co., Ltd. 021-20242659 18930833303
 Sales@changyanchem.cn China 5010 55
  • 2H-1,3,4-Benzotriazepin-2-one,1-[4-[(2-aMinoethyl)aMino]phenyl]-5-cyclohexyl-1,3-dihydro-8-Methyl-3-(tetrahydro-2H-pyran-4-yl)-
  • 916514-10-8
  • C28H37N5O2
Copyright 2019 © ChemicalBook. All rights reserved